Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique

Clinical Chemistry

Volumn 44, Issue 7, 1998, Pages 1570-1572

  Conejo, José Ramón ^a   Parra, Trinidad ^a   Cantero, Miguel ^a   Jiménez, Agustín ^a   Granizo, Vicente ^a   De Arriba, Gabriel ^a   Carballo, Fernando ^a  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ETHIDIUM BROMIDE;

ARTICLE; DNA DETERMINATION; HUMAN; HUMAN CELL; ONCOGENE RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; REPRODUCIBILITY; SCREENING TEST; TUMOR SUPPRESSOR GENE; URINE SEDIMENT;

CODON; DNA, NEOPLASM; GENES, RAS; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; URINARY BLADDER NEOPLASMS;

EID: 0031832052     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sidransky D, Von Eschenbach A. Tsai YC, Jones P, Summerhayes I, Marshall F, et al. Identification of p53 gene mutations in bladder cancer and urine samples. Science 1991:252:706-9.
2. Haliassos A, Liloglou T, Likourinas M, Doumas C, Ricci N, Spandidos DA. H-ras mutations in the urine of patients with bladder tumors: description of a non-invasive method for the detection of neoplasia. Int J Oncol 1992;1: 731-4.
3. Hruban RH, Van Der Riet P, Erozan Y, Sidransky D. Brief report: molecular biology and the early detection of carcinoma of the bladder-the case of Hubert Humphrey. N Engl J Med 1994;330:1276-8.
4. Fitzgerald JM, Ramchurrem N, Rieger K, Levesque P, Silverman M, Libertino JA, et al. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J Natl Cancer Inst 1995;87: 129-33.
5. Levi S, Urbano-Spizua A, Gill R, Thomas DM, Gilbertson J, Foster C, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991; 51:3497-502.
6. Hunter T. Cooperation between oncogenes. Cell 1991;64:249-70.
7. Czerniak B, Deitch D, Simmoons H, Etkind P, Herz F, Koss L. Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma. Br J Cancer 1990;62:762-3.
8. Burchill SA, Lunec J, Mellon K, Neal D. Analysis of Ha-ras mutations in primary human bladder tumours. Br J Cancer 1991;63(Suppl 3):62.
9. Ono T, Scalf M, Smith LM. 2′-fluoro modified nucleic acids: polymerase-directed synthesis, properties and stability to analysis by matrix-assisted laser desorption/ionization mass spectrometry. Nucleic Acids Res 1997: 25:4581-8.
10. Chen J, Viola MV. A method to detect ras point mutations in small subpopulations of cells. Anal Biochem 1991;195:51-6.
11. Nollau P, Moser C, Weinland G, Wagener C. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 1996;66:332-6.
12. Khan SM, Jiang W, Culbertson A, Weinstein IB, Williams GM, Tomita N, et al. Rapid and sensitive nonradioactive detection of mutant K-ras genes via "enriched" PCR amplification. Oncogene 1991;6:1079-83.
13. Nollau P, Wagener C Methods for detection of point mutations: performance and quality assessment. Clin Chem 1997;43:1114-28.
14. Voytas D. Resolution and recovery of large DNA fragments. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current protocols in molecular biology. Cambridge: John Wiley & Sons, 1996;2.5.1-2.5.9.
15. Knowles MA, Williamson M. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res 1993;53:133-9.
16. Burchill SA, Neal DE, Lunec J. Frequency of H-ras mutations in human bladder cancer detected by direct sequencing. Br J Urol 1994;73.516-21.
17. Saito S, Hata M, Fukuyama R, Sakai K, Kudoh J, Tazaki H, et al. Screening of H ras gene point mutations in 50 cases of bladder carcinoma. Int J Urol 1997;4:178-85.